Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of compounded chenodeoxycholic acid capsules
2021-003823-14Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of chenodeoxycholic acid in cerebrotendinous xanthomatosis (CTX), sponsored by Amsterdam University Medical Center. Primary endpoint: Pharmacokinetic parameters of chenodeoxycholic acid. Started Nov 2021; status: active.
02
Drugs
chenodeoxycholic acid
03
Conditions
cerebrotendinous xanthomatosis (CTX)
Beyond the preview
Go deeper on 2021-003823-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003823-14.